Eye Tracking and Autism in Former Preterm Infants (NCT07764822)
Eye-Tracking Biomarkers for Early Autism Detection in Former Preterm Infants
🩺 Plain-English Summary (8th-Grade Level)
This is a single center, intervention study of integrating the eye-tracking (ET) biomarker battery into the existing autism evaluation process at the Riley Early Years Program (EYP). Eligible participants referred for autism testing through EYP will undergo a traditional comprehensive diagnostic assessment by an EYP clinical psychologist.
Who can join: Review the eligibility criteria below.
Location: Riley Hospital for Children — Indianapolis, Indiana
Age range: 14 Months to 48 Months
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Riley Hospital for Children — Indianapolis, Indiana
📞 Contact the Study Coordinator
Phone: (317) 274-4708
Email: hsrakow@iu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Autism
- The Effectiveness of an Autistic-delivered Peer-support Intervention for Autistic Adults: Community Autism Peer Specialist (CAPS) Program — Philadelphia, Pennsylvania
- Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism — La Jolla, California
- Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial — Piscataway, New Jersey
- Culturally Adapted RUBI for Spanish-Speaking Families in Texas and Mexico — Waco, Texas
- An Open Label Study of CM-AT for the Treatment of Children With Autism — Phoenix, Arizona
- Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism — Piscataway, New Jersey
Explore by condition: All Autism clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.